Square Pharmaceuticals PLC
@squarepharma.com.bd
Square Pharmaceuticals is the flagship company of Square group which is one of the largest conglomerate in the country. The group’s turnover was over 1.56 billion US Dollar (2021) and employs over 66,000 people. Square pharmaceuticals is in manufacturing and marketing of finished pharmaceuticals products for the last 64 years. Manufacture of Active Pharmaceutical Ingredients (API) is a part of company business since in 1995. Since 1985 Square Pharma is the leader of Bangladesh Pharma market. 2020-2021 gross turnover of the company was over USD 690 Million (approx). The company has 17 manufacturing units in 2 different sites (Dhaka Site and Pabna Site) in Bangladesh. One other manufacturing units are under construction at Dhaka site and commissioning of those units are expected to be completed by end of 2024. Solid dosage manufacturing unit has been approved by USFDA, UK MHRA, and MCC South Africa. Square’s R&D center is well equipped with State-of-the-Art analytical tools. All the products are developed in-house for filing to regulated markets.
Square Pharmaceuticals PLC's Company Logos
Square Pharmaceuticals PLC's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#989697
Venus
152, 150, 151
330, 1, 59
0, 1, 1, 40
#8B9E42
Sycamore
139, 158, 66
72, 41, 44
12, 0, 58, 38
#FB986E
Atomic Tangerine
251, 152, 110
18, 95, 71
0, 39, 56, 2
About Square Pharmaceuticals PLC
Square Pharmaceuticals PLC, established in 1958, has become a leading name in the pharmaceutical sector of Bangladesh, being the largest pharmaceutical company in the country since 1985. With its commitment to quality and innovation, Square Pharmaceuticals has achieved a significant market share of approximately 16. 95%, demonstrating consistent growth.
The company excels in various product lines, including pharmaceutical products, herbal and nutraceutical items, as well as AgroVet and crop care solutions. Along with its comprehensive portfolio, Square is dedicated to expanding its reach in the global market, having pioneered medicine exports from Bangladesh in 1987, serving 42 countries worldwide. The company's operational success is supported by state-of-the-art facilities, including formulation units and an API unit, which bolster their production and distribution capabilities.
With a strong emphasis on corporate social responsibility, Square Pharmaceuticals aims to contribute positively to society while maintaining its status as a high-performance player on the international stage
